Rhythm Pharmaceuticals Inc
RYTM
$90.78+1.27%
End of day · as of Oct 10, 2026, 3:15 AM ET
Mkt cap
$6.49B
EV/Sales
34.5
P/E ratio
N/A
FY2025 Revenue
$189.76M
EPS (TTM)
$-3.12
Gross Margin (FY2025)
89.73%
Profit Margin (FY2025)
-103.57%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported RYTM revenue for 2025-12-31 was $189.8M. Net income was -$196.5M. Revenue was up 45.8% from 2024-12-31 to 2025-12-31. RYTM currently screens at market cap $6.49B.
Use this RYTM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RYTM income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company in the Healthcare sector.
Latest cached Rhythm Pharmaceuticals Inc (RYTM) revenue for Dec 31, 2025 was $189.8M. Net income was -$196.5M. Statements: https://lician.com/financials/rytm
Rhythm Pharmaceuticals Inc (RYTM) market capitalization is $6.49B on the latest cached snapshot.
Rhythm Pharmaceuticals Inc (RYTM) cached previous close $89.64; day range $89.41 – $93.35; volume 1,402,446. Session quote: https://lician.com/quote/rytm
Rhythm Pharmaceuticals Inc (RYTM) latest cached earnings event is "RYTM earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings